ClearPoint Neuro (CLPT) is scheduled to report Q1 earnings on May 12, 2026. Analysts estimate EPS of $-0.26 and quarterly revenue of $12.24M.
In the most recent quarter (Q4), ClearPoint Neuro reported EPS of $-0.23, missing estimates of $-0.21 by 0.10%. Revenue came in at $10.40M, exceeding the estimate of $9.91M by 0.05%.
ClearPoint Neuro has missed EPS estimates in 6 consecutive quarters.
Over the last 4 quarters, ClearPoint Neuro has averaged an EPS surprise of 0.14% and a revenue surprise of 0.05%.
Analyze the earnings history of ClearPoint Neuro using advanced sorting and filters.
The chart below shows ClearPoint Neuro's reported EPS compared to analyst estimates over recent quarters.
The chart below shows ClearPoint Neuro's reported revenue compared to analyst estimates over recent quarters.
ClearPoint Neuro (CLPT) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on March 17, 2026 for Q4.
The Actual EPS was $-0.23, which missed the estimate of $-0.21.
The Actual Revenue was $10.40M, which beat the estimate of $9.91M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-17 | $-0.23 | $-0.21 | -9.52 % |
| Q3 | 2025-11-06 | $-0.21 | $-0.20 | -5.00 % |
| Q2 | 2025-08-12 | $-0.21 | $-0.20 | -5.00 % |
| Q1 | 2025-05-13 | $-0.22 | $-0.16 | -37.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-17 | $10.40M | $9.91M | 4.94 % |
| Q3 | 2025-11-06 | $8.86M | $9.72M | -8.84 % |
| Q2 | 2025-08-12 | $9.22M | $9.32M | -1.13 % |
| Q1 | 2025-05-13 | $8.49M | $8.20M | 3.48 % |